Nutritional imbalances linking cellular senescence and type 2 diabetes mellitus

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 17, Issue 4, 2014, Pages 338-342

  Testa, Roberto ^a   Genovese, Stefano ^b   Ceriello, Antonio ^c,d  

^a INRCA   (Italy)

^b Department of Cardiovascular and Metabolic Diseases IRCCS Gruppo Multimedica   (Italy)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Cellular senescence; Diabetes mellitus; Nutrition

Indexed keywords

ALPHA TOCOPHEROL; CURCUMIN; ISOTHIOCYANIC ACID DERIVATIVE; NUTRACEUTICAL; VITAMIN D; TRACE ELEMENT;

CELL AGING; DIABETIC PATIENT; DIET; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL DEFICIENCY; OBESITY; REVIEW; ANIMAL; BLOOD; COMPLICATION; DEFICIENCY; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; LIFESTYLE; MALNUTRITION; MOTOR ACTIVITY; PATHOPHYSIOLOGY;

ANIMALS; CELL AGING; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HUMANS; LIFE STYLE; MALNUTRITION; MICRONUTRIENTS; MOTOR ACTIVITY;

EID: 84902298077     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000066     Document Type: Review

References (41)

1. Schellenberg ES, Dryden DM, Vandermeer B, et al. Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and metaanalysis. Ann Intern Med 2013; 159:543-551.
2. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013; 36 (Suppl 1):S11-S66.
3. Burton DGA. Cellular senescence, ageing and disease. Age 2009; 31:1-9.
4. Suram A, Kaplunov J, Patel PL, et al. Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions. EMBO J 2012; 31:2839-2851.
5. Haigis KM, Sweet-Cordero A. New insights into oncogenic stress. Nat Genet 2011; 43:177-178.
6. Guerra C, Collado M, Navas C, et al. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 2011; 19:728-739.
7. Campisi J, Andersen JK, Kapahi P, Melov S. Cellular senescence: a link between cancer and age-related degenerative disease? Semin Cancer Biol 2011; 21:354-359.
8. Tchkonia T, Morbeck DE, Von Zglinicki T, et al. Fat tissue, aging, and cellular senescence. Aging Cell 2010; 9:667-684.
9. Ksiazek K, Mikula-Pietrasik J, Olijslagers S, et al. Vulnerability to oxidative stress and different patterns of senescence in human peritoneal mesothelial cell strains. Am J Physiol Regul Integr Comp Physiol 2009; 296:R374-R382.
10. Burton DG, Sheerin AN, Ostler EL, et al. Cyclin D1 over-expression permits the reproducible detection of senescent human vascular smooth muscle cells. Ann N Y Acad Sci 2007; 1119:20-31.
11. Busik JV, Tikhonenko M, Bhatwadekar A, et al. Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J Exp Med 2009; 206:2897-2906.
12. Oikawa A, Siragusa M,Quaini F, et al. Diabetes mellitus induces bone marrow microangiopathy. Arterioscler Thromb Vasc Biol 2010; 30:498-508.
13. Humpert PM, Djuric Z, Zeuge U, et al. Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptordependent signaling. Mol Med 2008; 14:301-308.
14. Cesari F, Sofi F, Caporale R, et al. Relationship between exercise capacity, endothelial progenitor cells and cytochemokines in patients undergoing cardiac rehabilitation. Thromb Haemost 2009; 101:521-526.
15. Menegazzo L, Albiero M, Avogaro A, Fadini GP. Endothelial progenitor cells in diabetes mellitus. Biofactors 2012; 38:194-202.
16. Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 2007; 10:142-148.
17. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56:1761-1772.
18. Tsai TH, Chai HT, Sun CK, et al. Obesity suppresses circulating level and function of endothelial progenitor cells and heart function. J Transl Med 2012; 10:137.
19. Heida NM, Müller JP, Cheng IF, et al. Effects of obesity and weight loss on the functional properties of early outgrowth endothelial progenitor cells. J Am Coll Cardiol 2010; 55:357-367.
20. Lee JH, OKeefe JH, Bell D, et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52:1949-1956.
21. Yiu YF, Chan YH, Yiu KH, et al. Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J Clin Endocrinol Metab 2011; 96:E830-E835.
22. Yang HH, Son JK, Jung B, et al. Epifriedelanol from the root bark of Ulmus davidiana inhibits cellular senescence in human primary cells. Planta Med 2011; 77:441-449.
23. Shishodia S. Molecular mechanisms of curcumin action: gene expression. Biofactors 2013; 39:37-55.
24. Dinkova-Kostova AT, Kostov RV. Glucosinolates and isothiocyanates in health and disease. Trends Mol Med 2012; 18:337-347.
25. Mukherjee S, Gangopadhyay H, Das DK. Broccoli: a unique vegetable that protects mammalian hearts through the redox cycling of the thioredoxin superfamily. J Agric Food Chem 2008; 56:609-617.
26. Saldanha JF, Leal VD, Stenvinkel P, et al. Resveratrol: why is it a promising therapy for chronic kidney disease patients? Oxid Med Cell Longev 2013; 2013:963217.
27. Catalgol B, Batirel S, Taga Y, Ozer NK. Resveratrol: french paradox revisited. Frontiers in Pharmacology 2012; 3:1-18.
28. Li H, Fostermann U. Resveratrol: a multifunctional compound improving endothelial function. Cardiovasc Drugs Ther 2009; 23:425-429.
29. Spanier G, Xu H, Xia N, et al. Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol 2009; 60 (Suppl 4):111-116.
30. Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 2011; 14:612-622.
31. BrasnyóP, Molnár GA, MohásM, et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 2011; 106:383-389.
32. Mak JC. Potential role of green tea catechins in various disease therapies: progress and promise. Clin Exp Pharmacol Physiol 2012; 39:265-273.
33. Mandel SA, Amit T, Weinreb O, Youdim MBH. Understanding the broadspectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseases. J Alzheimers Dis 2011; 25:187-208.
34. Shanmugam MK, Kannaiyan R, Sethi G. Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutr Cancer 2011; 63:161-173.
35. Pan MH, Lai CS, Dushenkov S, Ho CT. Modulation of inflammatory genes by natural dietary bioactive compounds. J Agric Food Chem 2009; 57:4467-4477.
36. Bae JY, Kanamune J, Han DW, et al. Reversible regulation of cell cycle-related genes by epigallocatechin gallate for hibernation of neonatal human tarsal fibroblasts. Cell Transplant 2009; 18:459-469.
37. Han DW, Lee MH, Kim B, et al. Preventive effects of epigallocatechin-3- Ogallate against replicative senescence associated with p53 acetylation in human dermal fibroblasts. Oxid Med Cell Longev 2012; 2012:850684.
38. Nakamura YK, Omaye ST. Vitamin E-modulated gene expression associated with ROS generation. J Funct Foods 2009; 3:241-252.
39. Sen CK, Khanna S, Roy S. Tocotrienols in health and disease: The other half of the natural vitamin E family. Mol Aspects Med 2007; 28:692-728.
40. Makpol S, Abidin AZ, Sairin K, et al. gamma-Tocotrienol prevents oxidative stress-induced telomere shortening in human fibroblasts derived from different aged individuals. Oxid Med Cell Longev 2010; 3:35-43.
41. Makpol S, Durani LW, Chua KH, et al. Tocotrienol-rich fraction prevents cell cycle arrest and elongates telomere length in senescent human diploid fibroblasts. J Biomed Biotechnol 2011; 2011:506171.